MMP9 and central nervous system cancer: By immunoenzyme method (ELISA), Hormigo et al. observed that the levels of MMP-9 were higher in the sera samples of patients with high-grade glioma after surgery, while the MMP-9 concentrations were significantly lower in glioblastoma patients with no radiographic evidence of disease in comparison to the subjects with active tumor [23].